0000899243-23-018119.txt : 20230814
0000899243-23-018119.hdr.sgml : 20230814
20230814171345
ACCESSION NUMBER: 0000899243-23-018119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230811
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boston Megan
CENTRAL INDEX KEY: 0001808923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39267
FILM NUMBER: 231171955
MAIL ADDRESS:
STREET 1: LEVEL 14, 114 WILLIAM ST
CITY: MELBOURNE, VIC
STATE: C3
ZIP: 3000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Benitec Biopharma Inc.
CENTRAL INDEX KEY: 0001808898
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3940 TRUST WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 780-0819
MAIL ADDRESS:
STREET 1: 3940 TRUST WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-11
0
0001808898
Benitec Biopharma Inc.
BNTC
0001808923
Boston Megan
C/O BENITEC BIOPHARMA INC.
3940 TRUST WAY
HAYWARD
CA
94545
1
1
0
0
Executive Director
0
Common Stock
2023-08-11
4
P
0
25907
A
25907
D
Common Stock
20
I
By Boston Super Invest Pty A/C Boston Family Super
Common Warrants (right to buy)
3.86
2023-08-11
4
P
0
25907
A
2023-08-11
2028-08-11
Common Stock
25907
25907
D
Represents shares of common stock, par value $0.0001 per share (the "Common Stock") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93.
The reported number of shares has been adjusted to reflect the impact of the Issuer's 17-for-1 reverse stock split completed on July 26, 2023.
/s/ Megan Boston
2023-08-14